Antigen presented by major histocompatibility complex class I

The antigen presented by major histocompatibility complex class I refers to a peptide fragment bound to a class I MHC molecule on the surface of almost all nucleated cells. MHC class I molecules are integral membrane glycoproteins consisting of a heavy chain and β2-microglobulin, with the peptide-binding groove formed by the heavy chain. These molecules typically present peptides derived from endogenous proteins—either normal cellular components or pathogen-derived material—to cytotoxic T lymphocytes (CD8+ T cells)[3][1][2][6][4]. The function of the complex is crucial for immune surveillance, enabling detection and destruction of virally infected or malignant cells. Failure of the MHC class I antigen presentation pathway is a key mechanism by which tumors and viruses escape immune detection[8][2][3]. **Note:** - The designation “Antigen presented by major histocompatibility complex class I” refers to a *complex* between an antigenic peptide and MHC class I molecule, not a single conventional receptor/enzyme target as in pharmacology. - For specific targeting or structured databases, canonical names would generally reference the presenting molecule (e.g., "Major histocompatibility complex class I molecule”) or a specific HLA allotype (“HLA-A*02:01”), not the complex with any given peptide. - This is the reason for “is_incorrect: true”—the term is too generic and not aligned with single, canonical drug targets.

Other names

MHC class I antigen complexMHC I:peptide complexAntigen–MHC I complexpeptide–MHC class I complex

Enhanced immune recognition: Drugs/vaccines may increase antigen presentation to stimulate cytotoxic T cells Immune checkpoint blockade: Inhibitors block negative regulation, allowing T cells activated via antigen–MHC I complexes to attack target cells